Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 14, 2015; 21(14): 4391-4396
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4391
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4391
Table 1 Findings for currently described gastric myoepithelial tumors
Patient | Age (yr) | Gender | Tumor size (cm) | Diagnosis | Follow-up finding (mo) | Immunohistochemical findings |
Spivach et al[8], 2007 | 65 | Female | 5.5 | Parachordoma | NED1, 36 | CK+2, EMA+, S100+, VIM+, BU-, CD117-, CD10-, GFAP-, calponin-, calretinin-, P63 |
The present case | 61 | Female | 1.3 | Low graders myoepithelial carcinoma | NED, 10 | AE1/AE3+, CK+, EMA+, S100+, VIM+, synaptophysin+, DOG1-, desmin-, actin M851-, HMB-45-, melan-A(weak), CD117-, CD10(spotty), GFAP-, calretinin-, CD56 |
- Citation: Tseng CE, Hsieh YH, Wei CK, Huang HY, Chi CL. Myoepithelial carcinoma of the stomach: A diagnostic pitfall. World J Gastroenterol 2015; 21(14): 4391-4396
- URL: https://www.wjgnet.com/1007-9327/full/v21/i14/4391.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i14.4391